Growth Metrics

Quest Diagnostics (DGX) Operating Margin (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Operating Margin for 17 consecutive years, with 13.76% as the latest value for Q4 2025.

  • Quarterly Operating Margin fell 2.0% to 13.76% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14.1% through Dec 2025, up 47.0% year-over-year, with the annual reading at 14.1% for FY2025, 47.0% up from the prior year.
  • Operating Margin hit 13.76% in Q4 2025 for Quest Diagnostics, roughly flat from 13.71% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 24.26% in Q1 2021 to a low of 5.79% in Q4 2022.
  • Historically, Operating Margin has averaged 15.53% across 5 years, with a median of 14.85% in 2024.
  • Biggest five-year swings in Operating Margin: surged 1466bps in 2021 and later tumbled -1375bps in 2022.
  • Year by year, Operating Margin stood at 19.53% in 2021, then plummeted by -70bps to 5.79% in 2022, then skyrocketed by 102bps to 11.67% in 2023, then rose by 18bps to 13.77% in 2024, then dropped by 0bps to 13.76% in 2025.
  • Business Quant data shows Operating Margin for DGX at 13.76% in Q4 2025, 13.71% in Q3 2025, and 15.86% in Q2 2025.